| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.88B | +2.7% |
| Cost of Revenue | $817.8M | +5.6% |
| Gross Profit | $2.07B | +1.6% |
| R&D Expense | $450.2M | +1.6% |
| SG&A Expense | $332.8M | -6.0% |
| Operating Income | $266.2M | -30.0% |
| Pre-tax Income | $246.7M | -40.0% |
| Income Tax | $83.7M | -22.2% |
| Net Income | $163.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.40B | +72.1% |
| Accounts Receivable | $8.7M | -0.1% |
| Current Assets | $1.96B | +47.7% |
| Total Assets | $2.83B | +16.9% |
| Current Liabilities | $1.36B | +105.0% |
| Long-term Debt | $2.33B | +2.0% |
| Total Liabilities | $3.93B | +23.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $693.4M | -7.8% |
| Capital Expenditures | $15.4M | +8.3% |
| Investing Cash Flow | $32.1M | +160.4% |
| Financing Cash Flow | -$169.9M | +78.4% |
| Free Cash Flow | $678.0M | -8.2% |
| -46.3% |
| EPS (Basic) | $1.59 | -39.8% |
| EPS (Diluted) | $1.39 | -40.9% |
| Stockholders' Equity |
| -$1.10B |
| -44.7% |